The estimated Net Worth of Kathleen Skarvan is at least $3.27 Milión dollars as of 12 July 2023. Ms. Skarvan owns over 1,107 units of Electromed stock worth over $2,512,800 and over the last 12 years she sold ELMD stock worth over $11,989. In addition, she makes $748,268 as President, Chief Executive Officer a Director at Electromed.
Kathleen has made over 11 trades of the Electromed stock since 2012, according to the Form 4 filled with the SEC. Most recently she sold 1,107 units of ELMD stock worth $11,989 on 12 July 2023.
The largest trade she's ever made was exercising 65,000 units of Electromed stock on 27 February 2023 worth over $89,700. On average, Kathleen trades about 4,044 units every 125 days since 2012. As of 12 July 2023 she still owns at least 142,449 units of Electromed stock.
You can see the complete history of Ms. Skarvan stock trades at the bottom of the page.
Kathleen S. Skarvan serves as President, Chief Executive Officer, Director of the Company. Ms. Skarvan joined the Company in 2012 as Chief Executive Officer, became a director in 2013 and was appointed to the additional position of President in August 2015. Ms. Skarvan served as Vice President of Operations at OEM Fabricators from 2011 to 2012. Previously, Ms. Skarvan served in various roles at Hutchinson Technology Incorporated, most recently as the President of the Disk Drive Components Division from April 2007 until March 2011. As President of the Disk Drive Components Division, Ms. Skarvan managed a public company division with annual revenues in excess of $300 million. Ms. Skarvan also served as a Senior Vice President of Hutchinson Technology Incorporated from December 2010 to March 2011, and as Vice President of Sales & Marketing of the Disk Drive Components Division from October 2003 until April 2007. She has served on the Board of Trustees of the St. Cloud State University Foundation since June 2015 and in November 2018 joined the board of directors of Citizens Community Federal National Association, a wholly-owned subsidiary of Citizens Community Bancorp, Inc. Ms. Skarvan has a bachelor’s degree from St. Cloud State University. Among other attributes, skills, experiences and qualifications, our Board believes that, as the President and Chief Executive Officer of the Company, Ms. Skarvan is the person most familiar with the Company’s day to day operations and most capable of effectively identifying strategic priorities and leading the execution of strategy.
As the President, Chief Executive Officer a Director of Electromed, the total compensation of Kathleen Skarvan at Electromed is $748,268. There are no executives at Electromed getting paid more.
Kathleen Skarvan is 64, she's been the President, Chief Executive Officer a Director of Electromed since 2015. There are 5 older and 5 younger executives at Electromed. The oldest executive at Electromed Inc. is George Winn, 83, who is the Independent Director.
Kathleen's mailing address filed with the SEC is C/O CITIZENS COMMUNITY BANCORP, INC., 2174 EASTRIDGE CENTER, EAU CLAIRE, WI, 54701.
Over the last 14 years, insiders at Electromed have traded over $2,585,226 worth of Electromed stock and bought 684,801 units worth $2,582,707 . The most active insiders traders include Oak Partners, Llc Red, Stephen H. Craney a Kathleen Skarvan. On average, Electromed executives and independent directors trade stock every 84 days with the average trade being worth of $358,798. The most recent stock trade was executed by James L. Cunniff on 1 March 2024, trading 9,000 units of ELMD stock currently worth $137,250.
electromed, inc. is a minnesota-based company (nyse mkt: elmd) and the innovative leader in the development, manufacture, and worldwide sales of the smartvest® airway clearance system. the patented system uses high frequency chest wall oscillation (hfcwo), a better-tolerated alternative to chest physiotherapy (cpt), to deliver vigorous, yet comfortable airway clearance treatment for patients battling the consequences of retained secretions. hfcwo has been clinically proven to clear the lungs of excess mucus, improve and reduce lung infections for individuals suffering from various conditions including atelectasis, copd, bronchiectasis, neuromuscular diseases, and cystic fibrosis. electromed, inc. is accredited by the joint commission and is iso 13485:2003 and iso 9001:2008 certified.
Electromed executives and other stock owners filed with the SEC include: